Medical marijuana: Considerations for plan sponsors
April 1 ushered in a new era with respect to the medical use of marijuana in Canada. There are emerging implications for plan sponsors that…
- April 23, 2014 September 13, 2019
- 07:00
Top Stories in Expert Panel
Is Risk-Based Supervision Right for DC Plans?
World Bank paper says it's time to think about DC risk in a different way.
- April 15, 2014 September 13, 2019
- 13:08
ETFs and HFT: The Need for Speed
What does it mean for investors?
- April 9, 2014 September 13, 2019
- 13:46
Why Public Support Won’t Save the Auto Industry
A value investor's approach to car companies.
- April 9, 2014 September 13, 2019
- 13:42
Frontier ETFs: Looking for the next China
But are they ready for prime time?
- April 2, 2014 September 13, 2019
- 15:49
Is SRI Right For Pension Plans?
Feel good factor aside, it's not the best fit for most sponsors.
- April 2, 2014 September 13, 2019
- 15:35
How Overvalued Are Equity Markets?
To find out, we put Shiller's CAPE to the test.
- March 25, 2014 September 13, 2019
- 11:53
Want a Perfect PRPP? Go Passive
A simple way to minimize conflicts of interest.
- March 19, 2014 September 13, 2019
- 15:47
How to manage extreme risks
It’s hard to watch the news these days without hearing about the tug of war that’s going on between Russia and the Ukraine. As the…
- March 17, 2014 September 13, 2019
- 11:17
What employers need to know about rheumatoid arthritis
Over the past year or two, plan sponsors have likely noticed drugs treating rheumatoid arthritis (RA) suddenly appearing in their listing of top therapeutic classes…
- March 14, 2014 September 13, 2019
- 10:25
Toward a new Canadian retirement system
The Canadian retirement system is unproductive and inefficient, but how do we tame this administrative beast without toppling the entire system? Taming it requires simplicity,…
- March 13, 2014 September 13, 2019
- 10:32
Five things we learned at the ETF Summit
How are Canadian pension funds using ETFs?
- March 12, 2014 September 13, 2019
- 06:13